News Detail
New Delhi, 31 Jan 2024: The Subject Expert Committee (SEC), which advises the drug regulator on the drug trial and approval matters among others, has recommended to the regulator to grant permission to the US-based drug major Johnson & Johnson to import and market its psoriat......
View Details
Source : Pharmabiz
SEC
Johnson & Johnson
Tremfya
Guselkumab
QuantiFERON-TB
PsO
PsA
Related News
- AI can make drug-testing more precise, relevant to human biology (14-02-2025)
- Ayurvedic 'STONE NILL DS Syrup' claiming to treat 'Kidney Stones - Renal Calculi and Urethral Calculi' seized (14-02-2025)
- ED raids Niti Sen Bhatia's residence in Panipat (14-02-2025)
- Draft Guidelines for Processing Patent Applications of AYUSH Systems and Related Inventions (13-02-2025)
- FDA cracks down on online sale of MTP kits in Ghaziabad and Badaun, 227 seized (13-02-2025)
- Nepalese youth arrested with large quantity of drugs (13-02-2025)
- Seizure of Prohibited Drug Tablets in Pali (13-02-2025)
- Cosmetics with high methanol content seized in Kochi; used as aftershave (13-02-2025)
- ‘Sodium Phosphates Enema BP,’ claimed to treat ‘Convulsions’ seized (12-02-2025)
- Substandard Medicines issue raised in Rajya Sabha (12-02-2025)